Pharmatech Dominicana company information, Employees & Contact Information

Wilmington PharmaTech, on mission to boost US drug ingredient capacity, snares investment from PE firm Curewell Fierce Pharma

Retail investors are D&D Pharmatech Inc.'s (KOSDAQ:347850) biggest owners and were hit after market cap dropped ₩88b simplywall.st

Contract drug manufacturer to close Franklin County plant, lay off dozens KSDK

BNW Investment Acquires Poonglim Pharmatech, First Foray into Medical Industry Businesskorea

[JPM2025] D&D Pharmatech draws attention at JPM2025 following US partner’s Nasdaq listing koreabiomed.com

D&D Pharmatech Announces Completion of Patient Enrollment for a 48-Week Phase 2 Trial Evaluating the Effectiveness of DD01, a Long-Acting, Dual GLP-1/Glucagon Receptor Agonist, in the Treatment of MASH Business Wire

Is D&D Pharmatech (KOSDAQ:347850) In A Good Position To Deliver On Growth Plans? simplywall.st

D&D Pharmatech’s DD01 Phase 2 trial success boosts stock by over 20% - CHOSUNBIZ Chosun Biz

Pharmatech: The Art of AI-Driven Drug Design with Exscientia News-Medical

Novo Nordisk to build $220 mln raw materials plant in Denmark Reuters

Pharmatech Associates – a USP company Consulting and Training Services Contract Pharma

Korean biopharma companies gear up for global expansion at J.P. Morgan Healthcare Conference 2025 koreabiomed.com

Enabling the next wave of innovative drug therapies with speciality enzymes Pharmaceutical Technology

Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital Business Wire

D&D Pharmatech’s US partner starts North American study for oral GLP-1 obesity drug koreabiomed.com

USP/Pharmatech to Provide Pharmaceutical Continuous Manufacturing Capabilities for Drug Developers and Manufacturers Business Wire

D&D Pharmatech's US unit to work with NIH, Johns Hopkins for Parkinson's research koreabiomed.com

Pharmatech Associates Showcases Strategic Program Development for Drug Sponsors and Innovators at CPHI Barcelona 2023 Business Wire

D&D Pharmatech Announces Positive Phase 2 Results for DD01 in MASH with Robust Reductions in Liver Fat Accompanied by Improvements in Liver and Metabolic Health Business Wire

Actylis and Novo Nordisk Pharmatech Announce a Strategic Partnership for the Distribution of Benzalkonium Chloride in Targeted European Countries. Business Wire

Pharma Tech to close Union factory Missourian | Washington, MO

Caris Life Sciences Acquires Pharmatech PR Newswire

Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech GlobeNewswire

Partnership to supply medical cannabis to the German market MMJDaily

Quest PharmaTech Announces Results from AGM GlobeNewswire

South Florida CEO knew drugs were contaminated — and they went to children’s hospitals Miami Herald

D&D Pharmatech Granted Fast Track Designation from US FDA for DD01 for the Treatment of NASH/MASH Business Wire

Quest PharmaTech Provides Corporate Update GlobeNewswire

D&D Pharmatech Announces Agreement with Salubris Pharmaceuticals for Licensing and Development of DD01 in China Business Wire

Pharmatech Associates’ Board of Directors Appoints Sireesha Yadlapalli as Chief Executive Officer Business Wire

How tainted drugs get to market, and make sick patients sicker NBC News

D&D Pharmatech Announces Initiation of Dosing in a Phase 2 Trial Designed to Evaluate the Efficacy and Safety of DD01, a Long-Acting, Dual GLP-1/Glucagon Receptor Agonist in Overweight/Obese Subjects with MASLD/MASH Business Wire

Morocco starts construction of COVID vaccine plant Al Jazeera

Novo Nordisk Pharmatech to open new sales office in US medwatch.com

D&D Pharmatech, Metsera expand collaboration for new obesity, MASH treatments koreabiomed.com

Contract drug manufacturer to close Franklin County plant, lay off 84 The Business Journals

D&D Pharmatech completes US phase 2 dosing of MASH drug, eyes June data release koreabiomed.com

All liquid drugs made by Davie company recalled as FDA advises not to use them Miami Herald

StrongRoom AI: Administrators seek to sell pharmatech Australian Journal of Pharmacy

Novo Nordisk Pharmatech to Build New Factory in Denmark CHEManager

D&D Pharmtech scores US patent for MASH drug candidate DD01 koreabiomed.com

D&D Pharmatech's $137.1 Million Series B to Support Clinical Trials in Alzheimer's, Parkinson's and Fibrosis BioSpace

D&D Pharmatech receives FDA nod for phase 2 GLP-1R agonist trial for multiple sclerosis koreabiomed.com

Novo Nordisk Pharmatech and Novozymes enter into enzyme partnership medwatch.com

Pa. prisons make changes to drug tests after complaints of ‘false positives’ PennLive.com

Novo Nordisk Pharmatech Ranked Among the Top 1% of Companies in EcoVadis Sustainability Assessment Report Pharmaceutical Business review -

When Medicine Makes Patients Sicker KFF Health News

Novo Nordisk Pharmatech A/S Pharmaceutical Business review -

3 AI Breakthroughs Revolutionizing Pharma Tech Ops At Roche Bioprocess Online

Novo Nordisk plans new $220M raw ingredients plant in Denmark Fierce Pharma

Former FEF Chemicals Changes Identity Genetic Engineering and Biotechnology News

Under construction, Morocco vaccine plant to cover 60% of Africa's needs The Arab Weekly

Stallion Laboratories chooses Spectrum Pharmatech Consultants for OSD facility in Ahmedabad Cleanroom Technology

Telstra Health to fully own pharma tech provider Fred IT Mobi Health News

D&D Pharmatech surges to record high after Pfizer-Metsera takeover reports - CHOSUNBIZ Chosun Biz

Supreme Pharmatech successfully passed US FDA registration Nation Thailand

Pfizer acquisition of Metsera boosts D&D Pharmatech partnership value in Korea - CHOSUNBIZ Chosun Biz

Morocco starts construction of vaccine manufacturing centre Construction Digital

D&D Pharmatech's fibro disease drug candidate wins patent in Australia koreabiomed.com

Introducing Novo Nordisk Pharmatech: A Rebranding Initiative Transforms the Former FEF Chemicals BioProcess International

Celltrion aims to commercialize insulin pen by 2025 The Korea Herald

Praxis plans to exit D&D Pharmatech investment after significant stock surge - CHOSUNBIZ Chosun Biz

D&D Pharmatech pursues direct perpetual CB issuance without underwriter - CHOSUNBIZ Chosun Biz

WuXi PharmaTech Acquires XenoBiotic Laboratories, Expands U.S. Presence Bioprocess Online

D&D Pharmatech’s Development of New Drugs for Degenerative Brain Disease and Fibrosis 바이오스펙테이터

YYZ Pharmatech Inc. Announces Residency At JLABS In Toronto Canadian Manufacturing

Wuxi Pharmatech Well Positioned To Continue Growing As Independent Company; Will Receive Breakup Fee Of $30M Pharmaceutical Online

Chinese Consortium Acquires Ambrx For Undisclosed Sum Asian Scientist Magazine

Pharmatech Solutions Limited invents prescription printer News Ghana

D&D Pharmatech raises KRW 20 billion Series A investment 바이오스펙테이터

Rwanda, AfDB Sign Milestone Agreement To Host Continental PharmaTech Body KT PRESS

Missouri Manufacturer in Union Announces Mass Layoff 101theeagle.com